Open Access

Clinical significance of chromodomain helicase/ATPase DNA binding protein 1‑like and human mutL homolog 1 gene expression in cholangiocarcinoma

  • Authors:
    • Jingwen Hua
    • Shiniao Li
    • Changwen Huang
  • View Affiliations

  • Published online on: June 28, 2018     https://doi.org/10.3892/ol.2018.9043
  • Pages: 2989-2994
  • Copyright: © Hua et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cholangiocarcinoma is a highly malignant form of gastrointestinal cancer with an unfavorable prognosis. The novel oncogene chromodomain helicase/ATPase DNA binding protein 1‑like (CHD1L) has been confirmed to serve a vital role in numerous types of cancer, including liver cancer. Mismatch repair (MMR) is a common DNA repair process that contributes to the preservation of the integrity and stability of genetic substances. Human mutL homolog 1 gene (hMLH1) is an important MMR protein family member. The present study aimed to evaluate the pathological and clinical features of cholangiocarcinoma, and to investigate the clinical significance of CHD1L and hMLH1 expression in cholangiocarcinoma. A total of 108 samples from cholangiocarcinoma tumor tissues and 60 samples from normal bile duct tissue were obtained from patients admitted to The Second Affiliated Hospital of Nanchang University between May 2005 and May 2014. All cholangiocarcinoma cases were pathologically confirmed. The expression of CHD1L and hMLH1 was examined by immunohistochemistry analysis. The expression of CHD1L in cholangiocarcinoma (94.44%) was significantly higher than in normal bile duct tissues (40.00%). CHD1L expression was associated with gallstone history, serum carbohydrate antigen 19‑9 (CA19‑9) level and Tumor‑Node‑Metastasis (TNM) stage (P<0.05). hMLH1 expression in cholangiocarcinoma (77.78%) was significantly lower than in normal bile duct tissues (96.67%), and was associated with gender, age, serum CA19‑9 level, the presence of hepatitis B virus surface antigen, TNM stage and tumor diameter (P<0.05). Kaplan‑Meier survival curve analysis indicated that the 3‑year accumulative survival rates for CHD1L‑positive and ‑negative patients differed significantly (P<0.05; 17.90 and 83.33%, respectively). There was no statistically significant difference (P>0.05) between the 3‑year accumulate survival rates for hMLH1‑positive and ‑negative patients (38.90 and 33.30%, respectively). High CHD1L expression and low hMLH1 expression levels were observed in patients with cholangiocarcinoma, and their abnormal expression patterns were associated with the progression of malignancy and an unfavorable disease prognosis. Therefore, CHD1L and hMLH1 may be potential prognostic biomarkers for cholangiocarcinoma.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 16 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hua J, Li S and Huang C: Clinical significance of chromodomain helicase/ATPase DNA binding protein 1‑like and human mutL homolog 1 gene expression in cholangiocarcinoma. Oncol Lett 16: 2989-2994, 2018
APA
Hua, J., Li, S., & Huang, C. (2018). Clinical significance of chromodomain helicase/ATPase DNA binding protein 1‑like and human mutL homolog 1 gene expression in cholangiocarcinoma. Oncology Letters, 16, 2989-2994. https://doi.org/10.3892/ol.2018.9043
MLA
Hua, J., Li, S., Huang, C."Clinical significance of chromodomain helicase/ATPase DNA binding protein 1‑like and human mutL homolog 1 gene expression in cholangiocarcinoma". Oncology Letters 16.3 (2018): 2989-2994.
Chicago
Hua, J., Li, S., Huang, C."Clinical significance of chromodomain helicase/ATPase DNA binding protein 1‑like and human mutL homolog 1 gene expression in cholangiocarcinoma". Oncology Letters 16, no. 3 (2018): 2989-2994. https://doi.org/10.3892/ol.2018.9043